Table of Content

1 Market Overview of Adeno-Associated Virus Gene Therapy
1.1 Adeno-Associated Virus Gene Therapy Market Overview
1.1.1 Adeno-Associated Virus Gene Therapy Product Scope
1.1.2 Adeno-Associated Virus Gene Therapy Market Status and Outlook
1.2 Global Adeno-Associated Virus Gene Therapy Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2033)
1.4 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Region (2018-2023)
1.5 Global Adeno-Associated Virus Gene Therapy Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
1.6.1 North America Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
1.6.2 Europe Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
1.6.3 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
1.6.4 Latin America Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
1.6.5 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size (2018-2033)
2 Adeno-Associated Virus Gene Therapy Market by Type
2.1 Introduction
2.1.1 Gene Silencing
2.1.2 Gene Replacement
2.1.3 Gene Addition
2.1.4 Gene Editing
2.2 Global Adeno-Associated Virus Gene Therapy Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Adeno-Associated Virus Gene Therapy Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Adeno-Associated Virus Gene Therapy Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Adeno-Associated Virus Gene Therapy Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue Breakdown by Type (2018-2033)
3 Adeno-Associated Virus Gene Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Research Institute
3.1.3 Others
3.2 Global Adeno-Associated Virus Gene Therapy Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Adeno-Associated Virus Gene Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Adeno-Associated Virus Gene Therapy Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Adeno-Associated Virus Gene Therapy Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Adeno-Associated Virus Gene Therapy Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue Breakdown by Application (2018-2033)
4 Adeno-Associated Virus Gene Therapy Competition Analysis by Players
4.1 Global Adeno-Associated Virus Gene Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2022)
4.3 Date of Key Players Enter into Adeno-Associated Virus Gene Therapy Market
4.4 Global Top Players Adeno-Associated Virus Gene Therapy Headquarters and Area Served
4.5 Key Players Adeno-Associated Virus Gene Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Adeno-Associated Virus Gene Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Creative Biolabs
5.1.1 Creative Biolabs Profile
5.1.2 Creative Biolabs Main Business
5.1.3 Creative Biolabs Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.1.4 Creative Biolabs Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Creative Biolabs Recent Developments
5.2 Affinia Therapeutics
5.2.1 Affinia Therapeutics Profile
5.2.2 Affinia Therapeutics Main Business
5.2.3 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.2.4 Affinia Therapeutics Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Affinia Therapeutics Recent Developments
5.3 Spark Therapeutics
5.3.1 Spark Therapeutics Profile
5.3.2 Spark Therapeutics Main Business
5.3.3 Spark Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.3.4 Spark Therapeutics Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 AGC Biologics Recent Developments
5.4 AGC Biologics
5.4.1 AGC Biologics Profile
5.4.2 AGC Biologics Main Business
5.4.3 AGC Biologics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.4.4 AGC Biologics Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 AGC Biologics Recent Developments
5.5 StrideBio
5.5.1 StrideBio Profile
5.5.2 StrideBio Main Business
5.5.3 StrideBio Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.5.4 StrideBio Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 StrideBio Recent Developments
5.6 SIRION Biotech
5.6.1 SIRION Biotech Profile
5.6.2 SIRION Biotech Main Business
5.6.3 SIRION Biotech Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.6.4 SIRION Biotech Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 SIRION Biotech Recent Developments
5.7 Neurophth Biotechnology
5.7.1 Neurophth Biotechnology Profile
5.7.2 Neurophth Biotechnology Main Business
5.7.3 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.7.4 Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Neurophth Biotechnology Recent Developments
5.8 Belief BioMed
5.8.1 Belief BioMed Profile
5.8.2 Belief BioMed Main Business
5.8.3 Belief BioMed Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.8.4 Belief BioMed Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Belief BioMed Recent Developments
5.9 BiBo Biopharma Engineering Co., Ltd.
5.9.1 BiBo Biopharma Engineering Co., Ltd. Profile
5.9.2 BiBo Biopharma Engineering Co., Ltd. Main Business
5.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.9.4 BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Developments
5.10 Beihai Kangcheng
5.10.1 Beihai Kangcheng Profile
5.10.2 Beihai Kangcheng Main Business
5.10.3 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.10.4 Beihai Kangcheng Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Beihai Kangcheng Recent Developments
5.11 PackGene Biotech
5.11.1 PackGene Biotech Profile
5.11.2 PackGene Biotech Main Business
5.11.3 PackGene Biotech Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.11.4 PackGene Biotech Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 PackGene Biotech Recent Developments
5.12 Sarepta Therapeutics
5.12.1 Sarepta Therapeutics Profile
5.12.2 Sarepta Therapeutics Main Business
5.12.3 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.12.4 Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Sarepta Therapeutics Recent Developments
5.13 Carbon BioSciences
5.13.1 Carbon BioSciences Profile
5.13.2 Carbon BioSciences Main Business
5.13.3 Carbon BioSciences Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.13.4 Carbon BioSciences Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Carbon BioSciences Recent Developments
5.14 Kelonia Therapeutics
5.14.1 Kelonia Therapeutics Profile
5.14.2 Kelonia Therapeutics Main Business
5.14.3 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.14.4 Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Kelonia Therapeutics Recent Developments
5.15 Roche
5.15.1 Roche Profile
5.15.2 Roche Main Business
5.15.3 Roche Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.15.4 Roche Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Roche Recent Developments
5.16 Remedium Bio
5.16.1 Remedium Bio Profile
5.16.2 Remedium Bio Main Business
5.16.3 Remedium Bio Adeno-Associated Virus Gene Therapy Products, Services and Solutions
5.16.4 Remedium Bio Adeno-Associated Virus Gene Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 Remedium Bio Recent Developments
6 North America
6.1 North America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Adeno-Associated Virus Gene Therapy Market Dynamics
11.1 Adeno-Associated Virus Gene Therapy Industry Trends
11.2 Adeno-Associated Virus Gene Therapy Market Drivers
11.3 Adeno-Associated Virus Gene Therapy Market Challenges
11.4 Adeno-Associated Virus Gene Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Adeno-Associated Virus Gene Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Adeno-Associated Virus Gene Therapy Market Size Share by Region (2018-2023)
Table 4. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Adeno-Associated Virus Gene Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Adeno-Associated Virus Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2024-2033)
Table 11. North America Adeno-Associated Virus Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Adeno-Associated Virus Gene Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Adeno-Associated Virus Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Adeno-Associated Virus Gene Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Adeno-Associated Virus Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Adeno-Associated Virus Gene Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Adeno-Associated Virus Gene Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Adeno-Associated Virus Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2024-2033)
Table 26. North America Adeno-Associated Virus Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Adeno-Associated Virus Gene Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Adeno-Associated Virus Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Adeno-Associated Virus Gene Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Adeno-Associated Virus Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Adeno-Associated Virus Gene Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Adeno-Associated Virus Gene Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Adeno-Associated Virus Gene Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adeno-Associated Virus Gene Therapy as of 2022)
Table 39. Date of Key Players Enter into Adeno-Associated Virus Gene Therapy Market
Table 40. Global Adeno-Associated Virus Gene Therapy Key Players Headquarters and Area Served
Table 41. Adeno-Associated Virus Gene Therapy Product Solution and Service
Table 42. Global Adeno-Associated Virus Gene Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Creative Biolabs Basic Information List
Table 45. Creative Biolabs Description and Business Overview
Table 46. Creative Biolabs Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Creative Biolabs (2018-2023)
Table 48. Creative Biolabs Recent Developments
Table 49. Affinia Therapeutics Basic Information List
Table 50. Affinia Therapeutics Description and Business Overview
Table 51. Affinia Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Affinia Therapeutics (2018-2023)
Table 53. Affinia Therapeutics Recent Developments
Table 54. Spark Therapeutics Basic Information List
Table 55. Spark Therapeutics Description and Business Overview
Table 56. Spark Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Spark Therapeutics (2018-2023)
Table 58. Spark Therapeutics Recent Developments
Table 59. AGC Biologics Basic Information List
Table 60. AGC Biologics Description and Business Overview
Table 61. AGC Biologics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of AGC Biologics (2018-2023)
Table 63. AGC Biologics Recent Developments
Table 64. StrideBio Basic Information List
Table 65. StrideBio Description and Business Overview
Table 66. StrideBio Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of StrideBio (2018-2023)
Table 68. StrideBio Recent Developments
Table 69. SIRION Biotech Basic Information List
Table 70. SIRION Biotech Description and Business Overview
Table 71. SIRION Biotech Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of SIRION Biotech (2018-2023)
Table 73. SIRION Biotech Recent Developments
Table 74. Neurophth Biotechnology Basic Information List
Table 75. Neurophth Biotechnology Description and Business Overview
Table 76. Neurophth Biotechnology Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Neurophth Biotechnology (2018-2023)
Table 78. Neurophth Biotechnology Recent Developments
Table 79. Belief BioMed Basic Information List
Table 80. Belief BioMed Description and Business Overview
Table 81. Belief BioMed Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Belief BioMed (2018-2023)
Table 83. Belief BioMed Recent Developments
Table 84. BiBo Biopharma Engineering Co., Ltd. Basic Information List
Table 85. BiBo Biopharma Engineering Co., Ltd. Description and Business Overview
Table 86. BiBo Biopharma Engineering Co., Ltd. Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of BiBo Biopharma Engineering Co., Ltd. (2018-2023)
Table 88. BiBo Biopharma Engineering Co., Ltd. Recent Developments
Table 89. Beihai Kangcheng Basic Information List
Table 90. Beihai Kangcheng Description and Business Overview
Table 91. Beihai Kangcheng Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Beihai Kangcheng (2018-2023)
Table 93. Beihai Kangcheng Recent Developments
Table 94. PackGene Biotech Basic Information List
Table 95. PackGene Biotech Description and Business Overview
Table 96. PackGene Biotech Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of PackGene Biotech (2018-2023)
Table 98. PackGene Biotech Recent Developments
Table 99. Sarepta Therapeutics Basic Information List
Table 100. Sarepta Therapeutics Description and Business Overview
Table 101. Sarepta Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Sarepta Therapeutics (2018-2023)
Table 103. Sarepta Therapeutics Recent Developments
Table 104. Carbon BioSciences Basic Information List
Table 105. Carbon BioSciences Description and Business Overview
Table 106. Carbon BioSciences Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Carbon BioSciences (2018-2023)
Table 108. Carbon BioSciences Recent Developments
Table 109. Kelonia Therapeutics Basic Information List
Table 110. Kelonia Therapeutics Description and Business Overview
Table 111. Kelonia Therapeutics Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Kelonia Therapeutics (2018-2023)
Table 113. Kelonia Therapeutics Recent Developments
Table 114. Roche Basic Information List
Table 115. Roche Description and Business Overview
Table 116. Roche Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Roche (2018-2023)
Table 118. Roche Recent Developments
Table 119. Remedium Bio Basic Information List
Table 120. Remedium Bio Description and Business Overview
Table 121. Remedium Bio Adeno-Associated Virus Gene Therapy Products, Services and Solutions
Table 122. Revenue (US$ Million) in Adeno-Associated Virus Gene Therapy Business of Remedium Bio (2018-2023)
Table 123. Remedium Bio Recent Developments
Table 124. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 125. North America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 126. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 127. Europe Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 128. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 129. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 130. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 131. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Share by Region (2018-2023)
Table 132. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Share by Region (2024-2033)
Table 133. Latin America Adeno-Associated Virus Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 134. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 135. Latin America Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 136. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 137. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 138. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 139. Adeno-Associated Virus Gene Therapy Market Trends
Table 140. Adeno-Associated Virus Gene Therapy Market Drivers
Table 141. Adeno-Associated Virus Gene Therapy Market Challenges
Table 142. Adeno-Associated Virus Gene Therapy Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adeno-Associated Virus Gene Therapy Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Adeno-Associated Virus Gene Therapy Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Adeno-Associated Virus Gene Therapy Market Share by Regions: 2022 VS 2033
Figure 4. Global Adeno-Associated Virus Gene Therapy Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Adeno-Associated Virus Gene Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Adeno-Associated Virus Gene Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Adeno-Associated Virus Gene Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Gene Silencing
Figure 11. Global Gene Silencing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Gene Replacement
Figure 13. Global Gene Replacement Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Gene Addition
Figure 15. Global Gene Addition Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Gene Editing
Figure 17. Global Gene Editing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Adeno-Associated Virus Gene Therapy Market Size Share by Type: 2022 & 2033
Figure 19. North America Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2033)
Figure 20. Europe Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue Market Share by Type (2018-2033)
Figure 24. Hospitals Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Research Institute Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Global Adeno-Associated Virus Gene Therapy Market Size Share by Application: 2022 & 2033
Figure 28. North America Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2033)
Figure 29. Europe Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2033)
Figure 30. Asia-Pacific Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2033)
Figure 31. Latin America Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2033)
Figure 32. Middle East and Africa Adeno-Associated Virus Gene Therapy Revenue Market Share by Application (2018-2033)
Figure 33. Adeno-Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Adeno-Associated Virus Gene Therapy Market Share in 2022
Figure 35. North America Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 36. United States Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 37. Canada Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 38. Germany Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 39. France Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 40. U.K. Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 41. Italy Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 42. Russia Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 43. Nordic Countries Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 44. Asia-Pacific Adeno-Associated Virus Gene Therapy Market Share by Region (2018-2033)
Figure 45. China Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 46. Japan Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 47. South Korea Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 49. India Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 50. Australia Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 51. Latin America Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 52. Mexico Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 53. Brazil Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Adeno-Associated Virus Gene Therapy Market Share by Country (2018-2033)
Figure 55. Turkey Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 57. UAE Adeno-Associated Virus Gene Therapy Market Size (2018-2033) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report